Skip to main content
Premium Trial:

Request an Annual Quote

'Announcement We've Been Waiting For'

"My Twitter feed just exploded," Matthew Herper says. "No one is talking about much else right now," the Broad Institute's Chad Nusbaum tells Forbes. "This is the megaton sequencing announcement we've been waiting for," Nick Loman writes at Pathogens: Genes and Genomes.

We are, of course, referring to Oxford Nanopore's announcement of two new DNA strand-sequencing systems at the Advances in Genome Biology and Technology meeting held on Marco Island, Fla., last week. (Our sister publication In Sequence has more on the GridIon and MinIon.)

In addition to sending shockwaves across the blogs and on Twitter — "ILMN [Illumina] cheers storing genomes on a USB stick while Oxford Nanopore was showing sequencing genomes with a USB stick," @rob_carlson writes, while @GenomeBiology says "Oxford Nanopore had everyone talking at lunch. Is the MinIon going to be the next-next-gen? Wow," and @Copenhagenomics calls the new technology "a potential game changer" — Nanopore's announcements shook up the stock market, presumably causing the declines observed in some sequencing companies' share values Friday afternoon. (GenomeWeb Daily News breaks those declines down.)

"Too many amazing @nanopore tweets to retweet them all," Loman says. Daily Scan couldn't agree more.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.